Angeles
Therapeutics

Angeles TherapeuticsAngeles TherapeuticsAngeles Therapeutics
  • Home
  • About
  • Scientific Founder
  • Our Science
    • Platforms
    • Intellectual Property
    • Pipeline
  • News
    • Publications
    • News and Media
  • Contact Us
  • More
    • Home
    • About
    • Scientific Founder
    • Our Science
      • Platforms
      • Intellectual Property
      • Pipeline
    • News
      • Publications
      • News and Media
    • Contact Us

Angeles
Therapeutics

Angeles TherapeuticsAngeles TherapeuticsAngeles Therapeutics
  • Home
  • About
  • Scientific Founder
  • Our Science
    • Platforms
    • Intellectual Property
    • Pipeline
  • News
    • Publications
    • News and Media
  • Contact Us

Our UNIQUE Platforms

SYNTHETIC IMMUNE RECEPTORS (SIR)

A next generation CAR-T platform that provides physiological T cell signaling.

 

NK-CAR PLATFORM

A next generation NK-CAR platform

 

BISPECIFIC AND MULTISPECIFIC PLATFORMS

Bispecific and multi-specific SIR-T and NK-CAR platforms

UNIVERSAL PLATFORMS


 Universal SIR and NK-CAR platforms

ALLOGENEIC PLATFORMS

Angeles platforms are fully compatible with allogeneic use

 

CAR-T TOXICITY MODULATORS

Use of Dasatinib to control CRS and other complications associated with cell therapies

CO-STIMULATION PLATFORM

A novel platform for providing selective NF-kappa B co-stimulus to CAR-T,  TCR-T and other cell therapy products


Platform for stem T cell isolation

A novel platform for  isolation of T stem cells for generation of cell therapy products


MATADOR CYTOTOXICITY ASSAYS

Novel luciferase based non-radioactive cellular cytotoxicity assays

TOPANGA ASSAY

A novel luciferase based assay to measure expression and affinity of cell therapy products


MALIBU-GLO ASSAY

A novel luciferase based assay for antibody engineering

Angeles Therapeutics

preet.chaudhary@angelestherapeutics.com

Copyright © 2021 Angeles Therapeutics, Inc - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept